mRNA COVID vaccine and myocarditis in adolescents

Comirnaty is safe and provides good antibody response, including for patients aged 12 to 15 years with clinical efficacy in protecting against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of 100%.1 On 14 June 2021, the Food and Health Bureau, Hong Kong SAR Government lowere...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hong Kong Medical Journal 2021-10, Vol.27 (5), p.326-327
Hauptverfasser:	Kwan, M Y W, Chua, G T, Chow, C B, Tsao, S S L, To, K K W, Yuen, K Y, Lau, Y L, Ip, P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Coronaviruses COVID-19 COVID-19 Vaccines Humans Multisystem inflammatory syndrome in children Myocarditis RNA, Messenger SARS-CoV-2 Teenagers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!